T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ares Management
ARES
$33.7B
| $39.7M | 0.01% |
579,984
+19,814
| +4% | +$1.43M |
|
727
Interparfums
IPAR
$3.7B
| $39.6M | 0.01% |
410,771
+997
| +0.2% | +$86.6K |
|
|
DOCU
728
DocuSign
DOCU
$12.2B
| $39.6M | 0.01% |
714,175
+425,463
| +147% | +$20.7M |
|
729
Eversource Energy
ES
$27.2B
| $39.5M | 0.01% |
471,619
+5,212
| +1% | +$413K |
|
730
Oneok
OKE
$58.4B
| $39.3M | 0.01% |
598,183
+2,688
| +0.5% | +$165K |
|
|
AJRD
731
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $39.3M | 0.01% |
702,154
+608,034
| +646% | +$30.1M |
|
732
SPX Corp
SPXC
$10.6B
| $39M | 0.01% |
594,547
+1,457
| +0.2% | +$95.4K |
|
733
Kroger
KR
$35.1B
| $38.4M | 0.01% |
861,727
-745
| -0.1% | -$34.2K |
|
734
Haemonetics
HAE
$4.11B
| $38.2M | 0.01% |
485,505
+79,532
| +20% | +$6.39M |
|
735
Addus HomeCare
ADUS
$2.2B
| $38.1M | 0.01% |
383,054
+552
| +0.1% | +$57.7K |
|
736
Crown Holdings
CCK
$12.9B
| $37.9M | 0.01% |
461,305
+87,009
| +23% | +$6.93M |
|
737
Franklin Resources
BEN
$17.2B
| $37.6M | 0.01% |
1,425,381
-37,084
| -3% | -$921K |
|
|
IGMS
738
DELISTED
IGM Biosciences
IGMS
| $37.5M | 0.01% |
2,206,407
-11,359
| -0.5% | -$227K |
|
739
Allogene Therapeutics
ALLO
$683M
| $37.4M | 0.01% |
5,941,797
+34,481
| +0.6% | +$319K |
|
740
Hexcel
HXL
$7.74B
| $37.3M | 0.01% |
634,076
-130,852
| -17% | -$7.49M |
|
741
Littelfuse
LFUS
$11.4B
| $37.3M | 0.01% |
169,181
-37,859
| -18% | -$8.45M |
|
742
Advanced Energy
AEIS
$13.2B
| $37.2M | 0.01% |
433,135
-29,913
| -6% | -$2.51M |
|
743
Celldex Therapeutics
CLDX
$3.35B
| $37.1M | 0.01% |
833,009
+87,001
| +12% | +$3.11M |
|
744
Euronet Worldwide
EEFT
$2.78B
| $37.1M | 0.01% |
393,133
-40,720
| -9% | -$3.53M |
|
745
Dick's Sporting Goods
DKS
$18.1B
| $37M | 0.01% |
307,403
+26,729
| +10% | +$3.01M |
|
746
Axalta
AXTA
$7.93B
| $36.9M | 0.01% |
1,449,554
-47,279
| -3% | -$1.17M |
|
747
Constellation Energy
CEG
$98.7B
| $36.9M | 0.01% |
428,245
+3,419
| +0.8% | +$308K |
|
748
Rocket Pharmaceuticals
RCKT
$367M
| $36.9M | 0.01% |
1,886,290
+246,647
| +15% | +$4.54M |
|
749
Casey's General Stores
CASY
$31.6B
| $36.5M | 0.01% |
162,638
+813
| +0.5% | +$185K |
|
750
D.R. Horton
DHI
$41.9B
| $36.5M | 0.01% |
409,254
-7,711
| -2% | -$618K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.